Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

NCT: NCT05731700 · COMPLETED

NCT IDNCT05731700
StatusCOMPLETED
Start Date2021-10-20
Completion2025-05-08
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this first in human study is to assess the safety and inhibition of restenosis of the CVT Everolimus-coated PTCA Catheter in the treatment of subjects presenting in-stent restenotic lesions in native coronary arteries.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑